ANALYSIS OF MATERNAL MORTALITY DUE TO HYPERTENSIVE DISEASES BETWEEN THE YEARS 2017 TO 2021

• Autor(a) principal: Costa , Maira Damasceno
• Data de Publicação: 2023
• Outros Autores: Costa , Maiane Damasceno, Massena , Thalita Pires, Cunha , Fernanda Ferreira Rodrigues da, Cunha , Fabiana Ferreira Rodrigues da, Barbosa , Thays Menezes Guimarães, Barbosa , Ana Regina Oliveira de Araújo, Lucena , Luana Ruthiele Chagas, Santos , Stefany Valery Gomes dos, Oliveira , Luanna Pinheiro de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/659
• topic: Mortalidade materna; Hipertensão; Saúde da Mulher; Mortality; hypertension; Women's Health

Introduction: Pregnancy is a transformative period in every woman's pregnancy cycle. During this process, numerous transformations can occur, mainly physiological changes, which are related to hormones. Associated with this, there are conditions that influence maternal mortality, characterized as a serious public health problem and with hypertensive diseases as direct causes of mortality. Objective: To analyze data on the epidemiological profile of maternal deaths due to hypertensive diseases. Methodology: This is an epidemiological and descriptive study, with information collected in the database through the Mortality Information System (SIM), managed by the Information Technology Department of the Unified Health System (DATASUS), with analysis of the profile of maternal deaths due to Hypertensive Syndromes during Pregnancy, in Brazil in the period 2017-2021, using the following ICD -10 codes: O10-Pre-existing hypertension with serious complication in childbirth and the postpartum period;O11-Pre-existing hypertensive disorder + superimposed proteinuria ; O14-Gestational hypertension without significant proteinuria; O15 Eclampsia; O16-Maternal hypertension NE. The criteria evaluated were: ethnicity/race, education, period and place of death. Results and Discussion: Data on maternal mortality due to hypertensive diseases were analyzed between the years 2017 and 2021. 2017 was the year with the highest rate of cases and the year 2021 was the lowest recorded. Women between the ages of 30 and 30 and from the Northeast and Southeast regions had the highest incidence of cases respectively. Conclusion: Therefore, the study contributes significantly to the construction of new data, highlighting the importance of building new prevention and screening strategies with the aim of reducing maternal mortality, ensuring safety in the pregnancy and puerperal cycle.